Calcium apatite deposition disease: Difference between revisions

Jump to navigation Jump to search
(Undo revision 1462824 by Manpreet Kaur (talk))
Line 73: Line 73:
   
   
=== Symptoms ===
=== Symptoms ===
*[Disease name] is usually asymptomatic.
*[[Calcium apatite deposition disease]] is usually asymptomatic.
*Symptoms of [disease name] may include the following:
*Symptoms of [[calcium apatite deposition disease]] may include the following:
:*[symptom 1]
*Acute episode of severe pain to chronic mild discomfort
:*[symptom 2]
*[symptom 2]
:*[symptom 3]
*[symptom 3]
:*[symptom 4]
*[symptom 4]
:*[symptom 5]
*[symptom 5]
:*[symptom 6]
*[symptom 6]
 
=== Physical Examination ===
=== Physical Examination ===
*Patients with [disease name] usually appear [general appearance].
*Patients with [disease name] usually appear [general appearance].

Revision as of 19:21, 16 April 2018

WikiDoc Resources for Calcium apatite deposition disease

Articles

Most recent articles on Calcium apatite deposition disease

Most cited articles on Calcium apatite deposition disease

Review articles on Calcium apatite deposition disease

Articles on Calcium apatite deposition disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Calcium apatite deposition disease

Images of Calcium apatite deposition disease

Photos of Calcium apatite deposition disease

Podcasts & MP3s on Calcium apatite deposition disease

Videos on Calcium apatite deposition disease

Evidence Based Medicine

Cochrane Collaboration on Calcium apatite deposition disease

Bandolier on Calcium apatite deposition disease

TRIP on Calcium apatite deposition disease

Clinical Trials

Ongoing Trials on Calcium apatite deposition disease at Clinical Trials.gov

Trial results on Calcium apatite deposition disease

Clinical Trials on Calcium apatite deposition disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Calcium apatite deposition disease

NICE Guidance on Calcium apatite deposition disease

NHS PRODIGY Guidance

FDA on Calcium apatite deposition disease

CDC on Calcium apatite deposition disease

Books

Books on Calcium apatite deposition disease

News

Calcium apatite deposition disease in the news

Be alerted to news on Calcium apatite deposition disease

News trends on Calcium apatite deposition disease

Commentary

Blogs on Calcium apatite deposition disease

Definitions

Definitions of Calcium apatite deposition disease

Patient Resources / Community

Patient resources on Calcium apatite deposition disease

Discussion groups on Calcium apatite deposition disease

Patient Handouts on Calcium apatite deposition disease

Directions to Hospitals Treating Calcium apatite deposition disease

Risk calculators and risk factors for Calcium apatite deposition disease

Healthcare Provider Resources

Symptoms of Calcium apatite deposition disease

Causes & Risk Factors for Calcium apatite deposition disease

Diagnostic studies for Calcium apatite deposition disease

Treatment of Calcium apatite deposition disease

Continuing Medical Education (CME)

CME Programs on Calcium apatite deposition disease

International

Calcium apatite deposition disease en Espanol

Calcium apatite deposition disease en Francais

Business

Calcium apatite deposition disease in the Marketplace

Patents on Calcium apatite deposition disease

Experimental / Informatics

List of terms related to Calcium apatite deposition disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

Historical Perspective

  • [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
  • In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
  • In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

Classification

  • [Disease name] may be classified according to [classification method] into [number] subtypes/groups:
  • [group1]
  • [group2]
  • [group3]
  • Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

  • The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
  • The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
  • On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
  • On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

Clinical Features

Differentiating [disease name] from other Diseases

  • [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
  • [Differential dx1]
  • [Differential dx2]
  • [Differential dx3]

Epidemiology and Demographics

  • The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
  • In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

  • Patients of all age groups may develop [disease name].
  • [Disease name] is more commonly observed among patients aged [age range] years old.
  • [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected with [disease name] than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

  • There is no racial predilection for [disease name].
  • [Disease name] usually affects individuals of the [race 1] race.
  • [Race 2] individuals are less likely to develop [disease name].

Risk Factors

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with [disease name] remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

  • The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms

Physical Examination

  • Patients with [disease name] usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings

  • There are no specific laboratory findings associated with [disease name].
  • A [positive/negative] [test name] is diagnostic of [disease name].
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
  • Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

  • There are no [imaging study] findings associated with [disease name].
  • [Imaging study 1] is the imaging modality of choice for [disease name].
  • On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
  • [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

  • [Disease name] may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • There is no treatment for [disease name]; the mainstay of therapy is supportive care.
  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action 1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

  • There are no primary preventive measures available for [disease name].
  • Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References

Template:WS Template:WH